1. Home
  2. CCRN vs SLDB Comparison

CCRN vs SLDB Comparison

Compare CCRN & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCRN
  • SLDB
  • Stock Information
  • Founded
  • CCRN 1986
  • SLDB 2013
  • Country
  • CCRN United States
  • SLDB United States
  • Employees
  • CCRN N/A
  • SLDB N/A
  • Industry
  • CCRN Professional Services
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CCRN Consumer Discretionary
  • SLDB Health Care
  • Exchange
  • CCRN Nasdaq
  • SLDB Nasdaq
  • Market Cap
  • CCRN 447.2M
  • SLDB 433.0M
  • IPO Year
  • CCRN N/A
  • SLDB 2018
  • Fundamental
  • Price
  • CCRN $12.27
  • SLDB $5.46
  • Analyst Decision
  • CCRN Hold
  • SLDB Strong Buy
  • Analyst Count
  • CCRN 5
  • SLDB 10
  • Target Price
  • CCRN $17.93
  • SLDB $15.00
  • AVG Volume (30 Days)
  • CCRN 347.9K
  • SLDB 787.2K
  • Earning Date
  • CCRN 11-05-2025
  • SLDB 11-05-2025
  • Dividend Yield
  • CCRN N/A
  • SLDB N/A
  • EPS Growth
  • CCRN N/A
  • SLDB N/A
  • EPS
  • CCRN N/A
  • SLDB N/A
  • Revenue
  • CCRN $1,192,539,000.00
  • SLDB N/A
  • Revenue This Year
  • CCRN N/A
  • SLDB N/A
  • Revenue Next Year
  • CCRN N/A
  • SLDB N/A
  • P/E Ratio
  • CCRN N/A
  • SLDB N/A
  • Revenue Growth
  • CCRN N/A
  • SLDB N/A
  • 52 Week Low
  • CCRN $9.58
  • SLDB $2.41
  • 52 Week High
  • CCRN $18.33
  • SLDB $8.14
  • Technical
  • Relative Strength Index (RSI)
  • CCRN 37.17
  • SLDB 45.95
  • Support Level
  • CCRN $11.09
  • SLDB $4.87
  • Resistance Level
  • CCRN $14.30
  • SLDB $5.77
  • Average True Range (ATR)
  • CCRN 0.65
  • SLDB 0.30
  • MACD
  • CCRN -0.11
  • SLDB -0.03
  • Stochastic Oscillator
  • CCRN 36.76
  • SLDB 55.87

About CCRN Cross Country Healthcare Inc. $0.0001 Par Value

Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: